What does a blood analyzer cost?
*Realistic acquisition pricing for hospital hematology systems, from entry-level benchtop to high-volume clinical platforms*
Buying guides, product comparisons, price estimates, and sourcing advice specific to blood analyzers. Neutral, procurement-literate research with sources.
*Realistic acquisition pricing for hospital hematology systems, from entry-level benchtop to high-volume clinical platforms*
Blood analyzers (hematology analyzers/CBC machines) are clinical IVD instruments that quantify and characterize cellular components of whole blood — RBCs, WBCs with differential, platelets, hemoglobin, hematocrit, and indices like MCV/MCH/MCHC. The hematology analyzer market was valued at USD 4.33 billion in 2025 and is projected to reach USD 7.28 billion by 2034, making this one of the most important diagnostic equipment investments facilities make annually. Buyers include hospital core labs, reference laboratories, physician office labs (POLs), urgent care/ASCs, oncology and ED point-of-care sites, and veterinary clinics — typically refreshing every 5–10 years or when CLIA scope, throughput, or LIS connectivity demands change.
These six vendors don't really compete with each other. They answer six different clinical questions, which makes the real comparison work simple: match your use case to the right vendor.